menu
    • menu

    Company profile for PolyPid

    NEW Drugs in Dev: 4
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications in the...
    We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications in the body over days to several months in a controlled manner.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PolyPidIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    18 Hasivim Street, P.O Box 7126 Petach Tikva, Israel 4959376
    Telephone
    Telephone
    +972-74-719-5700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.polypid.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/polypid
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PolyPid Completes NDA Submission to FDA for D-PLEX???
    PolyPid Completes NDA Submission to FDA for D-PLEX???

    01 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/01/3304355/0/en/polypid-completes-new-drug-application-submission-to-fda-for-d-plex.html

    GLOBENEWSWIRE
    01 Jun 2026
    Share Share
    PolyPid to Participate in Craig-Hallum Investor Conference
    PolyPid to Participate in Craig-Hallum Investor Conference

    20 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/20/3298464/0/en/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference.html

    GLOBENEWSWIRE
    20 May 2026
    Share Share
    Polypid Updates On Corporate Progress And Q1 2026 Financials
    Polypid Updates On Corporate Progress And Q1 2026 Financials

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3293895/0/en/polypid-provides-corporate-update-and-reports-first-quarter-2026-financial-results.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Polypid To Share Q1 2026 Financials And Highlights On May 13
    Polypid To Share Q1 2026 Financials And Highlights On May 13

    06 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/06/3288762/0/en/polypid-to-report-first-quarter-2026-financial-results-and-operational-highlights-on-may-13-2026.html

    GLOBENEWSWIRE
    06 May 2026
    Share Share
    PolyPid Shows Reduced SSI Severity in Phase 3 SHIELD II
    PolyPid Shows Reduced SSI Severity in Phase 3 SHIELD II

    28 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7231292

    FIRSTWORD PHARMA
    28 Apr 2026
    Share Share
    Polypid To Unveil D-PLEX??? Sustained Release Data At ESCMID 2026
    Polypid To Unveil D-PLEX??? Sustained Release Data At ESCMID 2026

    13 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/13/3272567/0/en/PolyPid-to-Present-New-Phase-3-SHIELD-II-Data-Demonstrating-D-PLEX-Sustained-Local-Release-at-ESCMID-Global-2026.html

    GLOBENEWSWIRE
    13 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search